Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | serine peptidase, clan SC, family S9A-like protein, putative | 0.0122 | 0.1117 | 0.3271 |
Trypanosoma brucei | prolyl endopeptidase | 0.0306 | 0.3415 | 1 |
Plasmodium falciparum | peptidase, putative | 0.0032 | 0 | 0.5 |
Schistosoma mansoni | glutaminase | 0.0268 | 0.2945 | 0.2945 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0122 | 0.1117 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0306 | 0.3415 | 1 |
Leishmania major | oligopeptidase b | 0.0122 | 0.1117 | 0.3271 |
Leishmania major | oligopeptidase B-like protein,serine peptidase, clan SC, family S9A-like protein | 0.0122 | 0.1117 | 0.3271 |
Mycobacterium tuberculosis | Probable protease II PtrBa [first part] (oligopeptidase B) | 0.0274 | 0.3015 | 1 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0032 | 0 | 0.5 |
Trypanosoma cruzi | prolyl endopeptidase | 0.0306 | 0.3415 | 1 |
Trypanosoma brucei | prolyl oligopeptidase, putative | 0.0122 | 0.1117 | 0.3271 |
Brugia malayi | glutaminase DH11.1 | 0.0268 | 0.2945 | 0.8623 |
Trichomonas vaginalis | glutaminase, putative | 0.0268 | 0.2945 | 1 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0032 | 0 | 0.5 |
Trypanosoma cruzi | oligopeptidase b | 0.0122 | 0.1117 | 0.3271 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0032 | 0 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Trypanosoma cruzi | oligopeptidase B-like protein, putative | 0.0122 | 0.1117 | 0.3271 |
Trypanosoma cruzi | oligopeptidase b | 0.0122 | 0.1117 | 0.3271 |
Plasmodium vivax | hypothetical protein, conserved | 0.0032 | 0 | 0.5 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0032 | 0 | 0.5 |
Echinococcus multilocularis | prolyl endopeptidase | 0.0306 | 0.3415 | 0.3415 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.1399 | 0.4097 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0032 | 0 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.1399 | 0.4097 |
Trypanosoma brucei | oligopeptidase b | 0.0122 | 0.1117 | 0.3271 |
Toxoplasma gondii | prolyl endopeptidase | 0.0306 | 0.3415 | 1 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0032 | 0 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.1399 | 0.4097 |
Loa Loa (eye worm) | hypothetical protein | 0.0306 | 0.3415 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0268 | 0.2945 | 0.8623 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0032 | 0 | 0.5 |
Onchocerca volvulus | Prolyl endopeptidase homolog | 0.0306 | 0.3415 | 1 |
Mycobacterium ulcerans | glutaminase | 0.0268 | 0.2945 | 1 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.0306 | 0.3415 | 1 |
Loa Loa (eye worm) | glutaminase | 0.0268 | 0.2945 | 0.8623 |
Trypanosoma brucei | serine peptidase, clan SC, family S9A-like protein | 0.0122 | 0.1117 | 0.3271 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0032 | 0 | 0.5 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Echinococcus granulosus | prolyl endopeptidase | 0.0306 | 0.3415 | 0.3415 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0306 | 0.3415 | 0.3415 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0306 | 0.3415 | 0.3415 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.